Overview

• The patient took the anti-androgen Androcur and its generic version for more than two decades to treat excessive hair growth and endometriosis
• She was diagnosed in 2013 with multiple benign meningiomas that caused vision problems, memory disorders and chronic fatigue
• A 2008 scientific article had highlighted a link between cyproterone acetate and brain tumors, but neither doctors nor drug labels conveyed the risk
• The court in Poitiers found a causal relationship and apportioned €300,000 in damages among Bayer, two other companies, a prescribing physician and a pharmacist
• The patient’s lawyer described the decision as a landmark precedent that could pave the way for similar compensation claims across Europe